Thyrocare Technologies Limited (THYROCARE.NS)
INR 999.0
(0.48%)
INR 999.0
(0.48%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 917 Million INR | 11.09% |
| 2022 | 813.9 Million INR | -59.51% |
| 2021 | 2.01 Billion INR | 42.45% |
| 2020 | 1.41 Billion INR | -0.38% |
| 2019 | 1.41 Billion INR | 9.72% |
| 2018 | 1.29 Billion INR | 2.17% |
| 2017 | 1.26 Billion INR | 25.33% |
| 2016 | 1 Billion INR | 29.42% |
| 2015 | 779.07 Million INR | 28.9% |
| 2014 | 604.4 Million INR | -3.4% |
| 2013 | 625.7 Million INR | 4.03% |
| 2012 | 601.49 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 352.2 Million INR | 12.6% |
| 2024 Q1 | 312.8 Million INR | 50.75% |
| 2023 Q4 | 207.5 Million INR | -1.1% |
| 2023 Q1 | 248.8 Million INR | 38.92% |
| 2023 FY | 904.2 Million INR | 11.09% |
| 2023 Q3 | 209.8 Million INR | -28.64% |
| 2023 Q2 | 294 Million INR | 18.17% |
| 2022 Q2 | 241.5 Million INR | -11.57% |
| 2022 Q4 | 179.1 Million INR | -11.77% |
| 2022 FY | 813.9 Million INR | -59.51% |
| 2022 Q1 | 273.1 Million INR | -2.18% |
| 2022 Q3 | 203 Million INR | -15.94% |
| 2021 Q3 | 280 Million INR | -65.49% |
| 2021 Q2 | 811.3 Million INR | 26.65% |
| 2021 Q1 | 640.6 Million INR | 46.79% |
| 2021 FY | 2.01 Billion INR | 42.45% |
| 2021 Q4 | 279.2 Million INR | -0.29% |
| 2020 Q4 | 436.4 Million INR | 4.45% |
| 2020 FY | 1.41 Billion INR | -0.38% |
| 2020 Q3 | 417.8 Million INR | -23.0% |
| 2020 Q2 | 542.6 Million INR | 3541.61% |
| 2020 Q1 | 14.9 Million INR | -93.37% |
| 2019 FY | 1.41 Billion INR | 9.72% |
| 2019 Q1 | 382.6 Million INR | 39.03% |
| 2019 Q2 | 439.3 Million INR | 14.82% |
| 2019 Q3 | 359.6 Million INR | -18.14% |
| 2019 Q4 | 224.6 Million INR | -37.54% |
| 2018 Q3 | 286.3 Million INR | -21.39% |
| 2018 FY | 1.29 Billion INR | 2.17% |
| 2018 Q2 | 364.2 Million INR | 2.53% |
| 2018 Q1 | 355.2 Million INR | 12.37% |
| 2018 Q4 | 275.2 Million INR | -3.88% |
| 2017 FY | 1.26 Billion INR | 25.33% |
| 2017 Q4 | 316.1 Million INR | -6.79% |
| 2017 Q3 | 339.13 Million INR | -1.54% |
| 2017 Q2 | 344.45 Million INR | 7.62% |
| 2017 Q1 | 320.07 Million INR | 13.33% |
| 2016 Q3 | 192.98 Million INR | -36.78% |
| 2016 Q2 | 305.25 Million INR | 19.89% |
| 2016 Q1 | 254.6 Million INR | -13.76% |
| 2016 Q4 | 282.42 Million INR | 46.35% |
| 2016 FY | 1 Billion INR | 29.42% |
| 2015 Q4 | 295.21 Million INR | 99.24% |
| 2015 Q2 | 248.81 Million INR | 49.4% |
| 2015 Q1 | 166.54 Million INR | 0.0% |
| 2015 FY | 779.07 Million INR | 28.9% |
| 2015 Q3 | 148.17 Million INR | -40.45% |
| 2014 FY | 604.4 Million INR | -3.4% |
| 2013 FY | 625.7 Million INR | 4.03% |
| 2012 FY | 601.49 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 711.88 Million INR | -28.814% |
| Dr. Lal PathLabs Limited | 8.65 Billion INR | 89.405% |
| Metropolis Healthcare Limited | 2.05 Billion INR | 55.385% |
| Vijaya Diagnostic Centre Limited | 3.62 Billion INR | 74.728% |
| Vimta Labs Limited | 1.22 Billion INR | 25.285% |